University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization Toronto, Ontario and Calgary, Alberta–(Newsfile Corp. – July 21, 2026) – Biosenta Inc. (CSE: ZRO) ("Biosenta") today highlighted new research…

Toronto, Ontario and Calgary, Alberta–(Newsfile Corp. – December 11, 2025) – Biosenta Inc. (CSE: ZRO) ("Biosenta") On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate…

Veteran paint and coatings industry leader brings decades of executive and regulatory expertise to support commercialization of Tri-Filler(R) antimicrobial technology Toronto, Ontario and Calgary, Alberta–(Newsfile Corp. – October 1, 2025) – Biosenta Inc. (CSE: ZRO) ("Biosenta")…

Former ATB Financial executive vice-president brings more than 35 years of capital-markets and corporate-banking experience to accelerate Biosenta's growth Toronto, Ontario and Calgary, Alberta–(Newsfile Corp. – July 21, 2025) – Biosenta Inc. (CSE: ZRO) ("Biosenta")…

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles Toronto, Ontario and Calgary, Alberta–(Newsfile Corp. – June 11, 2025) – Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that two…